Table 2.
Molecule | Experimental system | Up/down regulation | CF/TF | References |
---|---|---|---|---|
ADAMTS 4/5 | C, EC | Up | CF | [27,46,47,52] |
Aggrecan | C, F, EC, in vivo | Down | CF/TF/in vivo | [8,27,33,67,68] |
Collagen II | C, EC, in vivo | Down | CF | [10,25,27,52,67,68] |
COX-2 | C, F, EC, in vivo | Up | CF/TF | [22,23] |
IL-1β | C, F, EC, in vivo | Up | CF/TF/in vivo | [46,60,65] |
iNOS/NO | C, F, EC, | Up | CF/TF | [23,24] |
MMP-1 | C, F, EC, in vivo | Up | CF/TF | |
MMP-3 | C, F, CE | Up | TF/in vivo | [16,27,31,46,52,65] |
MMP-9 | C | Up | TF/in vivo | [52] |
MMP-13 | C | Up | CF/TF | [16,65] |
Proteoglycan | C, F, EC, in vivo | Down | CF/TF/in vivo | [25,27,33,52,55,60,65,66,69] |
TIMP I/II | EC | CF | [27,46] |
Abbreviations: C, chondrocytes; CE, cartilage explants; CF, compressive forces; F, fibrochondrocytes; TF, tensile forces.